Beximco Pharmaceuticals Limited Sustainability Profile
Beximco Pharmaceuticals Limited, often referred to as Beximco Pharma, is a leading player in the pharmaceutical industry, headquartered in Dhaka, Bangladesh (BD). Established in 1976, the company has made significant strides in the production of high-quality generic medicines, active pharmaceutical ingredients (APIs), and over-the-counter products, catering to both domestic and international markets. With a strong focus on research and development, Beximco Pharma has developed a diverse portfolio that includes formulations across various therapeutic areas, such as cardiology, oncology, and anti-infectives. The company is renowned for its commitment to quality and innovation, which has positioned it as a trusted name in the global pharmaceutical landscape. Notable achievements include regulatory approvals from prestigious agencies, underscoring its reputation for excellence and reliability in healthcare solutions.
DitchCarbon Score
How does Beximco Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beximco Pharmaceuticals Limited's score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Beximco Pharmaceuticals Limited's reported carbon emissions
Beximco Pharmaceuticals Limited, headquartered in Bangladesh (BD), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available from the company. As of now, Beximco Pharmaceuticals Limited has not inherited any emissions data from a parent or related organization, nor does it have any commitments to science-based targets (SBTi) or other climate initiatives. This lack of data suggests that the company may still be in the early stages of developing its climate strategy and emissions reporting framework. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction initiatives. Beximco Pharmaceuticals Limited may benefit from aligning with industry standards and setting measurable targets to enhance its environmental performance in the future.
How Carbon Intensive is Beximco Pharmaceuticals Limited's Industry?
How Carbon Intensive is Beximco Pharmaceuticals Limited's Location?
Beximco Pharmaceuticals Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Beximco Pharmaceuticals Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.